ECOLAB INC. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
ECOLAB INC. (ECL) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $479.50 million for the 3-month period ending 2024-12-31, per its 10-K filed 2025-02-21.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2025-02-21
- ECOLAB INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2024-12-31 was $479.50M, a 16.72% increase year-over-year.
- ECOLAB INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2024-09-30 was $740.80M, a 80.95% increase year-over-year.
- ECOLAB INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2024-06-30 was $495.00M, a 47.89% increase year-over-year.
- ECOLAB INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2024-03-31 was $416.60M, a 74.97% increase year-over-year.
- ECOLAB INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was $2.13B, a 53.04% increase from fiscal 2023.
- ECOLAB INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was $1.39B, a 25.62% increase from fiscal 2022.
- ECOLAB INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was $1.11B, a 3.07% decline from fiscal 2021.
- ECOLAB INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2021 was $1.14B, a 16.17% increase from fiscal 2020.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2024-12-31 | $479.50M 10-K · filed 2025-02-21 | $1.22B derived: sum of 2 quarters · filed 2025-02-21 | $1.72B derived: sum of 3 quarters · filed 2025-02-21 | $2.13B 10-K · filed 2025-02-21 |
| 2024-09-30 | $740.80M 10-K · filed 2025-02-21 | $1.24B derived: sum of 2 quarters · filed 2025-02-21 | $1.65B derived: sum of 3 quarters · filed 2025-02-21 | $2.06B derived: sum of 4 quarters · filed 2025-02-21 |
| 2024-06-30 | $495.00M 10-K · filed 2025-02-21 | $911.60M derived: sum of 2 quarters · filed 2025-02-21 | $1.32B derived: sum of 3 quarters · filed 2025-02-21 | $1.73B derived: sum of 4 quarters · filed 2025-02-21 |
| 2024-03-31 | $416.60M 10-K · filed 2025-02-21 | $827.40M derived: sum of 2 quarters · filed 2025-02-21 | $1.24B derived: sum of 3 quarters · filed 2025-02-21 | $1.57B derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-12-31 | $410.80M 10-K · filed 2025-02-21 | $820.20M derived: sum of 2 quarters · filed 2025-02-21 | $1.15B derived: sum of 3 quarters · filed 2025-02-21 | $1.39B 10-K · filed 2025-02-21 |
| 2023-09-30 | $409.40M 10-K · filed 2025-02-21 | $744.10M derived: sum of 2 quarters · filed 2025-02-21 | $982.20M derived: sum of 3 quarters · filed 2025-02-21 | $1.25B derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | $334.70M 10-K · filed 2025-02-21 | $572.80M derived: sum of 2 quarters · filed 2025-02-21 | $842.30M derived: sum of 3 quarters · filed 2025-02-21 | $1.19B derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | $238.10M 10-K · filed 2025-02-21 | $507.60M derived: sum of 2 quarters · filed 2025-02-21 | $859.60M derived: sum of 3 quarters · filed 2025-02-21 | $1.17B derived: sum of 4 quarters · filed 2025-02-21 |
| 2022-12-31 | $269.50M 10-K · filed 2024-02-23 | $621.50M derived: sum of 2 quarters · filed 2024-02-23 | $934.20M derived: sum of 3 quarters · filed 2024-02-23 | $1.11B 10-K · filed 2024-02-23 |
| 2022-09-30 | $352.00M 10-K · filed 2024-02-23 | $664.70M derived: sum of 2 quarters · filed 2024-02-23 | $839.40M derived: sum of 3 quarters · filed 2024-02-23 | $1.14B derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | $312.70M 10-K · filed 2024-02-23 | $487.40M derived: sum of 2 quarters · filed 2024-02-23 | $792.70M derived: sum of 3 quarters · filed 2024-02-23 | $1.12B derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | $174.70M 10-K · filed 2024-02-23 | $480.00M derived: sum of 2 quarters · filed 2024-02-23 | $808.60M derived: sum of 3 quarters · filed 2024-02-23 | $1.12B derived: sum of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | $305.30M 10-K · filed 2023-02-24 | $633.90M derived: sum of 2 quarters · filed 2023-02-24 | $947.50M derived: sum of 3 quarters · filed 2023-02-24 | $1.14B 10-K · filed 2023-02-24 |
| 2021-09-30 | $328.60M 10-K · filed 2023-02-24 | $642.20M derived: sum of 2 quarters · filed 2023-02-24 | $838.70M 10-Q · filed 2021-10-29 | $1.14B derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $313.60M 10-K · filed 2023-02-24 | $510.10M 10-Q · filed 2021-08-05 | $815.00M derived: sum of 3 quarters · filed 2023-02-24 | $1.06B derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $196.50M 10-K · filed 2023-02-24 | $501.40M derived: sum of 2 quarters · filed 2023-02-24 | $750.70M derived: sum of 3 quarters · filed 2023-02-24 | $885.00M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | $304.90M 10-K · filed 2022-02-25 | $554.20M derived: sum of 2 quarters · filed 2022-02-25 | $688.50M derived: sum of 3 quarters · filed 2022-02-25 | $984.80M 10-K · filed 2023-02-24 |
| 2020-09-30 | $249.30M 10-K · filed 2022-02-25 | $383.60M derived: sum of 2 quarters · filed 2022-02-25 | $679.90M 10-Q · filed 2021-10-29 | $1.08B derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $134.30M 10-K · filed 2022-02-25 | $430.60M 10-Q · filed 2021-08-05 | $830.30M derived: sum of 3 quarters · filed 2022-02-25 | $1.27B derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $296.30M 10-K · filed 2022-02-25 | $696.00M derived: sum of 2 quarters · filed 2022-02-25 | $1.14B derived: sum of 3 quarters · filed 2022-02-25 | $1.48B derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $399.70M 10-K · filed 2021-02-26 | $840.00M derived: sum of 2 quarters · filed 2021-02-26 | $1.19B derived: sum of 3 quarters · filed 2021-02-26 | $1.44B 10-K · filed 2022-02-25 |
| 2019-09-30 | $440.30M 10-K · filed 2021-02-26 | $787.60M derived: sum of 2 quarters · filed 2021-02-26 | $1.04B 10-Q · filed 2020-10-30 | $1.44B derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $347.30M 10-K · filed 2021-02-26 | $602.90M 10-Q · filed 2020-08-06 | $1.00B derived: sum of 3 quarters · filed 2021-02-26 | $1.33B derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $255.60M 10-K · filed 2021-02-26 | $654.00M derived: sum of 2 quarters · filed 2021-02-26 | $985.80M derived: sum of 3 quarters · filed 2021-02-26 | $1.31B derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $398.40M 8-K · filed 2020-09-25 | $730.20M derived: sum of 2 quarters · filed 2020-09-25 | $1.06B derived: sum of 3 quarters · filed 2020-09-25 | $1.27B 10-K · filed 2021-02-26 |
| 2018-09-30 | $331.80M 8-K · filed 2020-09-25 | $659.20M derived: sum of 2 quarters · filed 2020-09-25 | $867.50M derived: sum of 3 quarters · filed 2020-09-25 | |
| 2018-06-30 | $327.40M 8-K · filed 2020-09-25 | $535.70M derived: sum of 2 quarters · filed 2020-09-25 | ||
| 2018-03-31 | $208.30M 8-K · filed 2020-09-25 | |||
| 2017-12-31 | $1.37B 8-K · filed 2020-09-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| Longevity Health Holdings, Inc. (XAGE) | United States | $0.006B | -0.09 |
| PROCTER & GAMBLE Co (PG) | United States | $338.763B | 21.26 |